최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국식품영양과학회지 = Journal of the Korean Society of Food Science and Nutrition, v.34 no.6, 2005년, pp.743 - 749
권지영 (국립수산과학원 남해수산연구소) , 남택정 (부경대학교 식품생명공학부)
Estrogen is known to play an important role in maintaining bone mass, since the concentration of serum estrogen decrease after menopause and the estrogen deficiency results in bone loss. Phytoestrogens are plant compounds with estrogen-like biological activity, In this study, to investigate the bioa...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Shils ME, Young VR. 1988. Modern nutrition in health and disease. 7th ed. Lea and Febiger Publisher, Philadelphia. p 763
Christenson RH. 1997. Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573-593
Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. 1990. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels. J Bone Miner Res 5: 311-319
Prestwood KM, Pilbeam CC, Raisz LG. 1995. Treatment of osteoporosis. Annu Rev Med 46: 249-256
Anderson JJ, Garner SC. 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557
Lindsay R. 1993. Pathogenesis of postmenopausal osteoporosis. Baillieres Clin Rheumato 7: 499-513
Gallagher JC, Bishop CW, Knutson JC, Mazess RB, DeLuca HF. 1994. Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 9: 607-614
Ettinger B, Genant HK, Cann CE. 1985. Long-term estrogen replacement therapy prevents bone loss and fracture. Ann Intern Med 102: 319-324
Edward MW, Bain SD, Bailey MC, Lantry MM, Howard GA. 1992. 17 $\beta$ -estradiol stimulation of endosteal bone formation in the ovariectomized mouse: an animal model for evaluation of bone targeted estrogens. Bone 13: 29-34
Ernst M, Heath JK, Rodan GA. 1989. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125: 825-833
Tomkinson A, Reeve J, Shaw RW, Noble BS. 1997. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128-3135
Vedi S, Purdie DW, Ballard P, Bord S. Cooper AC, Compston JE. 1999. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Osteoporos Int 10: 52-58
McCarthy TL, Centrella M. 1993. Regulation of IGF activity in bone. Adv Exp Med Bio 343: 407-414
Genant HK, Baylink DJ, Gallagher JC. 1989. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 1842-1846
Murphy LJ, Ghahary A. 1990. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocrine Rev 11: 443-453
Anderson JJ, Garner SC 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557
Adlercreutz H, Mazur W. 1997. Phyto-oestrogens and Western diseases. Ann Med 29: 95-120
Setchell KDR. 1998. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333-1346
Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. 1999. Health potential of soy isoflavones for menopausal women. Public Health Nut 2: 489-504
Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. 2001. Soy bean ethanol extract increases the function of osteoblastic MC3T3-El cells. Phytochemistry 56: 733-739
Setchell KDR, Cassidy A. 1999. Dietary isoflavones: biological effects and relevance to human health. J Nutr 129: 758-767
Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja Sc. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167
Gao YH, Yamaguchi M. 1999. Anabolic effect of daidzein on cortical in tissue culture: Comparison with genistein effect. Mol Cell Biochem 194: 93-98
Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. 1998. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375-1379
Panti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH. 1998 The phytoestrogen genistein reduces bone loss in short-term ovariactomized rats. Osteoporo Int 8: 274-281
Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167
Gehm BD, McAndrews JM, Chien PY, Jameson JL. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143
Mizutani K, Ikeda K, Kawai Y, Yamori Y. 1998. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-El cells. Biochem Biophys Res Commun 253: 859-863
Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. 2000. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130: 1675-1681
Ljunghall S, Lindh E. 1989. Assesment of bone turnover with biochemical makers. J Intern Med 225: 219-220
Wlodarski KH, Reddi AH. 1986. Alkaline phosphatase as a marker of osteoinductive cells. Calcif Tissue Int 39: 382-385
Sugimoto E, Yamaguchi M. 2000a. Anabolic effect of genistein in osteoblastic MC3T3-El cells. Int J Mol Med 5: 515-520
Sugimoto E, Yamaguchi M. 2000b. Stimulatory effect of daidzein in osteoblastic MC3T3-El cells. Biochem Pharmacol 59: 471-475
Ernst M, Rodan GA. 1991. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 8: 1081-1089
Nasu M, Sugimoto T, Kaji H, Chihara K. 2000. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cell: role of insulin like growth factor (IGF)-I and IGF-binding prtein-5. J Endocrinol 167: 305-313
Huynh H. 1998. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor 1. Int J Oncol 12: 427-432
Shinar DM, Endo N, Halperin D, Rodan GA, Weinreb M. 1993. Differential expression of insulin-like growth factor-1 (IGF-I) and IGF-II messenger ribonucleic acid in rowin rat bone. Endocrinology 132: 1158-1167
Lazowski D, Fraher L, Hodsman A, Steer B, Modrowski D, Han V. 1994. Regional variation of insulin like growth factor-I gene expression in mature rat bone and cartilage. Bone 15: 563-576
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.